CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- Open-market buys, last 90 days
- $291,587
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$291,587. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-28 | Baskies Arnold M Director | Purchase | +5,000 | $2.82 | $14K | 120,000 |
| 2025-01-24 | Titterton Lewis H jr Director | Purchase | +1,000 | $3.00 | $3K | 933,334 |
| 2025-01-23 | Titterton Lewis H jr Director | Purchase | +2,000 | $2.91 | $6K | 932,334 |
| 2025-01-22 | Titterton Lewis H jr Director | Purchase | +2,000 | $3.01 | $6K | 930,334 |
| 2025-01-21 | Titterton Lewis H jr Director | Purchase | +6,000 | $2.59 | $16K | 928,334 |
| 2025-01-17 | Titterton Lewis H jr Director | Purchase | +10,000 | $2.57 | $26K | 922,334 |
| 2025-01-15 | KUMAR AMIT Chief Executive Officer | Purchase | +43,000 | $2.23 | $96K | 559,925 |
| 2025-01-15 | Catelani Michael President, COO, & CFO | Purchase | +9,289 | $2.15 | $20K | 44,500 |
| 2025-01-02 | Titterton Lewis H jr Director | Grant or award · Employee Stock Option | +25,000 | 25,000 | ||
| 2025-01-02 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option | +700,000 | 700,000 | ||
| 2025-01-02 | Gottschalk Emily Director | Grant or award · Employee Stock Option | +25,000 | 25,000 | ||
| 2025-01-02 | Catelani Michael President, COO & CFO | Grant or award · Employee Stock Option | +350,000 | 350,000 | ||
| 2025-01-02 | Baskies Arnold M Director | Grant or award · Employee Stock Option | +25,000 | 25,000 | ||
| 2024-10-22 | Titterton Lewis H jr Director | Option exercise | +16,000 | $2.58 | $41K | 912,334 |
| 2024-10-22 | Titterton Lewis H jr Director | Option exercise · Employee Stock Option | −16,000 | 0 | ||
| 2024-07-31 | Titterton Lewis H jr Director | Purchase | +5,580 | $3.23 | $18K | 896,334 |
| 2024-07-30 | Titterton Lewis H jr Director | Purchase | +21,646 | $3.06 | $66K | 890,754 |
| 2024-07-26 | Titterton Lewis H jr Director | Purchase | +7,700 | $3.03 | $23K | 869,108 |
| 2024-07-26 | Baskies Arnold M Director | Purchase | +5,000 | $3.09 | $15K | 115,000 |
| 2024-07-25 | Titterton Lewis H jr Director | Purchase | +796 | $2.81 | $2K | 861,408 |
Page 3 of 21 · 404 trades